TEXAS CAPITAL BANCSHARES INC (TCBI)

US88224Q1076 - Common Stock

58.68  +2.7 (+4.82%)

After market: 58.68 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TCBI. TCBI was compared to 412 industry peers in the Banks industry. TCBI may be in some trouble as it scores bad on both profitability and health. TCBI is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

TCBI had positive earnings in the past year.
In the past year TCBI had a positive cash flow from operations.
Each year in the past 5 years TCBI has been profitable.
Of the past 5 years TCBI 4 years had a positive operating cash flow.

1.2 Ratios

TCBI has a worse Return On Assets (0.61%) than 74.76% of its industry peers.
The Return On Equity of TCBI (5.37%) is worse than 80.83% of its industry peers.
Industry RankSector Rank
ROA 0.61%
ROE 5.37%
ROIC N/A
ROA(3y)0.8%
ROA(5y)0.69%
ROE(3y)7.67%
ROE(5y)7.16%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TCBI has a Profit Margin of 15.98%. This is in the lower half of the industry: TCBI underperforms 77.67% of its industry peers.
TCBI's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for TCBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 15.98%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y43.94%
PM growth 5Y-10.96%
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

TCBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
TCBI has less shares outstanding than it did 1 year ago.
The number of shares outstanding for TCBI has been reduced compared to 5 years ago.
The debt/assets ratio for TCBI has been reduced compared to a year ago.

2.2 Solvency

TCBI has a debt to FCF ratio of 2.41. This is a good value and a sign of high solvency as TCBI would need 2.41 years to pay back of all of its debts.
TCBI has a Debt to FCF ratio (2.41) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.27 indicates that TCBI is not too dependend on debt financing.
TCBI's Debt to Equity ratio of 0.27 is in line compared to the rest of the industry. TCBI outperforms 44.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 2.41
Altman-Z N/A
ROIC/WACCN/A
WACC18.56%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

5

3. Growth

3.1 Past

TCBI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.89%, which is quite impressive.
The Earnings Per Share has been decreasing by -9.37% on average over the past years.
Looking at the last year, TCBI shows a very negative growth in Revenue. The Revenue has decreased by -12.21% in the last year.
Measured over the past years, TCBI shows a small growth in Revenue. The Revenue has been growing by 1.61% on average per year.
EPS 1Y (TTM)46.89%
EPS 3Y47.2%
EPS 5Y-9.37%
EPS growth Q2Q-15.38%
Revenue 1Y (TTM)-12.21%
Revenue growth 3Y0.67%
Revenue growth 5Y1.61%
Revenue growth Q2Q-53.2%

3.2 Future

Based on estimates for the next years, TCBI will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.16% on average per year.
The Revenue is expected to grow by 2.91% on average over the next years.
EPS Next Y5.38%
EPS Next 2Y10.98%
EPS Next 3Y11.16%
EPS Next 5YN/A
Revenue Next Year0.73%
Revenue Next 2Y3.78%
Revenue Next 3Y2.91%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.58 indicates a correct valuation of TCBI.
Compared to the rest of the industry, the Price/Earnings ratio of TCBI indicates a rather expensive valuation: TCBI more expensive than 82.28% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of TCBI to the average of the S&P500 Index (24.76), we can say TCBI is valued slightly cheaper.
With a Price/Forward Earnings ratio of 15.73, TCBI is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TCBI indicates a slightly more expensive valuation: TCBI is more expensive than 73.06% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.26, TCBI is valued a bit cheaper.
Industry RankSector Rank
PE 16.58
Fwd PE 15.73

4.2 Price Multiples

TCBI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TCBI is cheaper than 60.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.79
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.08
PEG (5Y)N/A
EPS Next 2Y10.98%
EPS Next 3Y11.16%

0

5. Dividend

5.1 Amount

No dividends for TCBI!.
Industry RankSector Rank
Dividend Yield N/A

TEXAS CAPITAL BANCSHARES INC

NASDAQ:TCBI (4/19/2024, 3:30:01 PM)

After market: 58.68 0 (0%)

58.68

+2.7 (+4.82%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.78B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 16.58
Fwd PE 15.73
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)3.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 5.37%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 15.98%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)46.89%
EPS 3Y47.2%
EPS 5Y
EPS growth Q2Q
EPS Next Y5.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-12.21%
Revenue growth 3Y0.67%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y